Detected ·

Addex Therapeutics

$2.8M—

Swiss biotech Addex Therapeutics raised USD 2.8M in gross proceeds via an at-the-market programme with H.C. Wainwright & Co., extending its cash runway into Q4 2027.

Amount
$2 800 000 USD
Stage
—
Event
Funding round
Detected
2026-09-02 12:06:58 UTC
Signal ID
22cece17-1d21-4013-b983-0a00b79e5177

As the API returns it

{
  "id": "22cece17-1d21-4013-b983-0a00b79e5177",
  "created_at": "2026-09-02T12:06:58.075517Z",
  "company_name": "Addex Therapeutics",
  "company_website_url": "www.addextherapeutics.com",
  "company_linkedin_url": "https://www.linkedin.com/company/addex-therapeutics",
  "event_type": "funding",
  "funding_amount": 2800000,
  "funding_currency": "USD",
  "funding_stage": null,
  "message": "*Swiss biotech Addex Therapeutics raised USD 2.8M in gross proceeds via an at-the-market programme with H.C. Wainwright & Co., extending its cash runway into Q4 2027.*"
}

Latest rounds